Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Baron Discovery Fund Randy Gwirtzman | “We initiated a position in Waystar Holding Corp., which provides a full spectrum of revenue cycle management software to health care providers. The company services 30,000 clients and processes 6 billion transactions per year, representing about half of all U.S. patients. Waystar's software automates intake, clinical documentation, and post-care billing, increasingly using AI to reduce denied claims and manual processes. The acquisition of Iodine Software completed an end-to-end claims automation solution. We believe roughly 80% of the market remains manually managed, leaving a long runway for share gains, margin expansion, and free cash flow growth. BSD Analysis: Waystar operates in the most broken part of U.S. healthcare: getting paid. Its revenue cycle management software helps providers navigate billing codes, denials, and insurer bureaucracy. That pain point isn't going away — it's getting worse. Once installed, Waystar becomes mission-critical because cash flow literally depends on it. Growth is driven by provider consolidation and complexity, not discretionary IT spend. Margins expand as automation replaces manual labor. Regulatory noise is constant, but it favors incumbents with scale. This is not healthcare innovation. It's payment survival infrastructure for providers under pressure.” | BULL | Q4 2025 Dec 31, 2025 | View Pitch |
Artisan Global Discovery Jason White | “Waystar is a leading cloud-based revenue cycle management platform that supports over 30,000 health care organizations, including 16 of the top 20 US hospitals. We initiated a position based on our view that Waystar is well positioned to benefit from the fallout of last year's cyberattack on its largest competitor, Change Healthcare. While provider switching takes time, early signs indicate this shift is underway. Additionally, we believe Waystar stands to gain from integrating AI capabilities into its software, delivering measurable ROI by automating denial management and prior authorizations, helping providers overcome staffing constraints and improve claims performance. BSD Analysis: The thesis is that competitive dislocation plus AI automation drive share gains and efficiency ROI. With sticky workflows and large installed base, revenue durability is high; expanding modules can lift ARPU and margins.” | BULL | Q3 2025 Oct 22, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
